How the Clinical Treatment Act is Increasing Diverse Access to Trials

SCRS Talks

English - April 18, 2022 12:00 - 14 minutes - 9.98 MB
Business scrs clinical research pharmaceuticals clinical trials Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Meet Mohammad Millwala, SCRS Leadership Council Member

Next Episode: Celebrating 10 Years of SCRS with Clare Grace

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act. This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, who shares more insight into this new law and how it may affect enrollment of diverse communities in trials.